This article has multiple issues. Please help
improve it or discuss these issues on the
talk page. (
Learn how and when to remove these template messages)
|
Company type | Private |
---|---|
Industry | Health care |
Founded | 2005 |
Founder | Christophe Llorens ( CEO) |
Headquarters |
Geneva (GE), Switzerland |
Area served | Worldwide |
Key people | Raphael Llorens |
Website |
zsimplants |
Zephyr Surgical Implants (ZSI) is a Swiss-based medical device manufacturer that produces and distributes artificial urinary sphincters and penile implants worldwide. ZSI products are used in the management of moderate-to-severe urinary incontinence in men, erectile dysfunction, Peyronie's disease, penis enlargement, and female-to-male gender reassignment surgery.
The company was founded by Dr. Christophe Llorens and Raphael Llorens in 2005. [1] The first product – ZSI 375 artificial urinary sphincter, was introduced in 2009. [2] [3] As of 2019, more than 4500 ZSI 375 artificial urinary sphincters were implanted worldwide. [2] The inflatable penile implant designed for female-to-male gender reassignment surgeries became available in the European market in March 2016, and the first phalloplasty procedures using ZSI 475 FtM implants were performed in June 2016. [4]
Many clinical studies have been performed with the artificial urinary sphincter ZSI 375 in the treatment of moderate and severe stress incontinence, most of them are retrospective and non-randomized tests. Success rates in total or social continence vary, in a period of 6 to 24 months, between 68 and 89%. [5] [6]
This article has multiple issues. Please help
improve it or discuss these issues on the
talk page. (
Learn how and when to remove these template messages)
|
Company type | Private |
---|---|
Industry | Health care |
Founded | 2005 |
Founder | Christophe Llorens ( CEO) |
Headquarters |
Geneva (GE), Switzerland |
Area served | Worldwide |
Key people | Raphael Llorens |
Website |
zsimplants |
Zephyr Surgical Implants (ZSI) is a Swiss-based medical device manufacturer that produces and distributes artificial urinary sphincters and penile implants worldwide. ZSI products are used in the management of moderate-to-severe urinary incontinence in men, erectile dysfunction, Peyronie's disease, penis enlargement, and female-to-male gender reassignment surgery.
The company was founded by Dr. Christophe Llorens and Raphael Llorens in 2005. [1] The first product – ZSI 375 artificial urinary sphincter, was introduced in 2009. [2] [3] As of 2019, more than 4500 ZSI 375 artificial urinary sphincters were implanted worldwide. [2] The inflatable penile implant designed for female-to-male gender reassignment surgeries became available in the European market in March 2016, and the first phalloplasty procedures using ZSI 475 FtM implants were performed in June 2016. [4]
Many clinical studies have been performed with the artificial urinary sphincter ZSI 375 in the treatment of moderate and severe stress incontinence, most of them are retrospective and non-randomized tests. Success rates in total or social continence vary, in a period of 6 to 24 months, between 68 and 89%. [5] [6]